Literature DB >> 2916625

Oral contraceptive use and the risk of chlamydial and gonococcal infections.

W C Louv1, H Austin, J Perlman, W J Alexander.   

Abstract

Oral contraceptive users were compared with nonusers with respect to the rate of cervical infections by Chlamydia trachomatis and Neisseria gonorrhoeae. The comparison was adjusted for differences in demographic and behavioral characteristics between the two groups. The rates of infection among oral contraceptive users were increased by approximately 70% (statistically significant) for both pathogens. Cervical ectopy was implicated in the increased rate of chlamydia but not gonorrhea. Rates of gonorrheal infection differed significantly among oral contraceptive formulations; rates were higher for formulations containing more androgenic progestins.

Entities:  

Keywords:  Age Factors; Bacterial And Fungal Diseases; Behavior; Biology; Cervical Effects; Cervix; Chlamydia--etiology; Comparative Studies; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Methods--side effects; Demographic Factors; Diseases; Endocrine System; Family Planning; Genital Effects, Female; Genitalia; Genitalia, Female; Gonorrhea--etiology; Hormones; Infections; Norethindrone--side effects; Norgestrel--side effects; Oral Contraceptives--side effects; Physiology; Population; Population At Risk; Population Characteristics; Reproductive Control Agents; Reproductive Tract Infections; Research Methodology; Risk Factors; Sex Behavior; Sexually Transmitted Diseases; Studies; Urogenital Effects; Urogenital System; Uterine Effects; Uterus

Mesh:

Substances:

Year:  1989        PMID: 2916625     DOI: 10.1016/0002-9378(89)90456-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  25 in total

Review 1.  Vaginal douching: evidence for risks or benefits to women's health.

Authors:  Jenny L Martino; Sten H Vermund
Journal:  Epidemiol Rev       Date:  2002       Impact factor: 6.222

2.  Chlamydia trachomatis and oral contraceptive use: a quantitative review.

Authors:  J Cottingham; D Hunter
Journal:  Genitourin Med       Date:  1992-08

3.  Hormonal contraception and area of cervical ectopy: a longitudinal assessment.

Authors:  Patricia L Bright; Abigail Norris Turner; Charles S Morrison; Emelita L Wong; Cynthia Kwok; Irina Yacobson; Rachel A Royce; Heidi O Tucker; Paul D Blumenthal
Journal:  Contraception       Date:  2011-03-23       Impact factor: 3.375

4.  Risk factors for gonorrhoea: case-control study.

Authors:  M Bjekić; H Vlajinac; S Sipetić; J Marinković
Journal:  Genitourin Med       Date:  1997-12

Review 5.  Risk for malignant tumors after oral contraceptive use: is it related to organ size while taking the pill?

Authors:  H Olsson
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

Review 6.  Preventing HIV infection in women: a global health imperative.

Authors:  Quarraisha Abdool Karim; Sengeziwe Sibeko; Cheryl Baxter
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

7.  Teenage health.

Authors:  G Gardner
Journal:  Br J Gen Pract       Date:  1995-03       Impact factor: 5.386

Review 8.  Pathogenesis of pelvic inflammatory disease.

Authors:  L Weström; P Wölner-Hanssen
Journal:  Genitourin Med       Date:  1993-02

9.  Chlamydia trachomatis among sexually active teenage girls: influence of sampling location and clinical signs on the detection rate.

Authors:  V A Rahm; V Odlind; H Gnarpe
Journal:  Genitourin Med       Date:  1990-04

10.  Predictors of chlamydial infection and gonorrhea among patients seen by private practitioners.

Authors:  J Vincelette; J G Baril; R Allard
Journal:  CMAJ       Date:  1991-03-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.